Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine ED50 and ED95 for bronchoscopy response under ciprofol sedation
ChiCTR2400086635Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in bronchoscopy (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Tracheal response rate during bronchoscopy examination. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
bronchoscopy
Beyond the preview
Go deeper on ChiCTR2400086635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086635.